Prepregnancy overweight and obesity are associated with higher risk of perinatal complications. However, the effect of weight change prior to pregnancy on perinatal outcome is largely unknown. Therefore, it is aimed to examine the impact on perinatal outcomes of interpregnancy BMI change in women of different BMI categories.
The prevalence of overweight and obesity in women of reproductive age has reached epidemic proportions and is associated with health risks for both mother and child. Risk factors including maternal overweight and obesity immediately before pregnancy and excessive gestational weight gain have been associated with adverse perinatal outcomes, such as gestational diabetes mellitus (GDM), preeclampsia, cesarean section, large (LGA) and small (SGA) for gestational age, and preterm birth. [1] [2] [3] These risk factors are often preceded by a certain lifestyle including unhealthy food and insufficient physical activity. 4, 5 In turn, these lifestyle-related environmental exposures during fetal and neonatal development can lead to epigenetic changes resulting in fetal and metabolic programming. 6 This programming influences the risk of cardiometabolic derangements and subsequent noncommunicable diseases in childhood and adult life and contributes therefore to the intergenerational transmission of health risks. [6] [7] [8] It is however unknown whether these adverse effects of overweight and obesity are caused merely by the static situation of the body mass index (BMI) that women have at the start of their pregnancy, or that these are the result of an increase in BMI in the period prior to pregnancy. At the same time, the effects of weight reduction in the preconception phase are an unexplored field as well.
Although the World Health Organization emphasizes the need for preconception care, 9 there is still a lack of studies regarding the effects of preconception weight change and lifestyle interventions on perinatal outcome. As a substitute, interpregnancy weight change-defined as change in maternal preconception weight from first to second pregnancies-offers a unique opportunity to collect data on weight change before the subsequent pregnancy. Therefore, the aim of this review is to study the impact of interpregnancy weight or BMI change between two consecutive pregnancies on perinatal outcomes in women with underweight, normal weight, overweight, and obesity before the first pregnancy.
| METHODS
A protocol for this systematic review and meta-analysis was prospectively registered in the International Prospective register of systematic reviews (PROSPERO; 2016: CRD42016043307). 10 
| Search strategy
The MEDLINE (Ovid; search strategy in Text S1), EMBASE (Ovid), LILACS, and CINAHL databases were searched for relevant studies from 1990 to August 2019. The following keywords and variations of these terms were included: "body weight," "weight loss," "weight gain," "obesity," "body mass index," "change," "birth intervals,"
"consecutive pregnancies," and "between gestation." The searches were limited to human studies. The search strategy was verified by an information specialist using the Peer Review of Electronic Search Strategies (PRESS) checklist. 11 
| Study eligibility criteria
To answer the prognostic research question, observational (longitudinal, cohort, and case-control) studies were included. An article was considered eligible and was included if it concerned the difference in prepregnancy weight or BMI between two consecutive singleton pregnancies. In order to answer the research question for the general population, studies were excluded in which only women with perinatal complications in the first pregnancy had been included.
Studies were excluded if they did not report on any of the following outcomes of interest: GDM, gestational hypertension (GH), preeclampsia, caesarean section, preterm birth, SGA, and LGA.
Inclusion of studies was not restricted by language, publication date, country, or duration of the interpregnancy interval.
Titles and abstracts of studies retrieved from the search strategy and, subsequently, full texts of potentially eligible studies were screened independently by two reviewers (YT and EO). Any disagreement regarding eligibility was discussed with a third reviewer until consensus was reached.
| Quality assessment and data synthesis
Meta-analyses were performed where possible: when at least two studies used the same outcome parameters and comparable categories of weight or BMI change. Odds ratios (ORs) adjusted for potential confounders were extracted from the studies and included in the meta-analysis that reported these data. Where needed, the number of events in each BMI change category was calculated based on the provided adjusted ORs in the studies. In some cases, BMI change categories were merged in order to equalize BMI change categories of different studies, which enabled the combination of these studies in a meta-analysis. 3 | RESULTS
| Study selection
A total number of 16,223 articles were retrieved from the search.
After removal of duplicates, 12,303 titles and abstracts were eligible for screening. In 122 studies, full text was assessed for eligibility, of which 30 articles were included in this review and eleven articles were included in the meta-analyses (see PRISMA flow diagram 14 ; Figure 1 ). 
| Study characteristics

| Data extraction
In Figures 2 and 3 , pooled adjusted ORs are shown for the association between interpregnancy BMI change and adverse perinatal outcomes.
Figures S1 to S7 show forest plots for each individual outcome. Table 1 shows the results of the meta-regression analyses.
FIGURE 1
Flowchart of literature search according to the PRISMA flow diagram. n = number. *Exact breakdown for exclusion not documented
| Gestational diabetes mellitus
Eleven studies assessed GDM, [15] [16] [17] [18] [19] [20] of which five studies [21] [22] [23] [24] [25] were eligible for the meta-analysis. The meta-analysis found a significant, positive association between interpregnancy BMI gain and GDM development during the second pregnancy ( Figure S1 : OR . BMI, body mass index; GDM, gestational diabetes mellitus; GH, gestational hypertension; 95%CI, 95% confidence interval Table 1 ). In the studies of Glazer et al 15 Knight-Agarwal et al 16 McBain et al 17 Lu et al 18 Whiteman et al 19 and Bender et al 20 (not included in the metaanalysis), the results were comparable to the meta-analysis. It was demonstrated that the effects of interpregnancy BMI gain on the risk for developing GDM were highest in women with normal weight before the first pregnancy (Table S8) . 17, [21] [22] [23] For mothers with overweight or obesity before the first pregnancy, interpregnancy BMI loss decreased the risk of GDM. 17, 22 Changing to a lower BMI category decreased the risk of developing GDM. 
| Gestational hypertension
In six studies, GH was assessed. 20, 21, 23, 24, 26, 27 Four studies were included in the meta-analysis, 21, 23, 24, 27 which resulted in a nonsignifi- Note: Meta-regression was used to determine if subgroups were significantly different in effect size. The coefficient is the difference in odds ratio between subgroups. Significant probability values indicate that the two groups compared were significantly different in the outcome studied. The first subgroup that is mentioned is used as reference group.
Abbreviations: BMI, body mass index; 95%CI, 95% confidence interval; GDM, gestational diabetes mellitus; GH, gestational hypertension;
LGA, large for gestational age; SGA, small for gestational age.
Meta-regression found that effect sizes were significantly different between subgroups (Table 1 ). The lowest effect size was found for the subgroup of BMI loss of ≥1 kg/m 2 and the highest effect size for the subgroup of BMI gain of ≥3 kg/m 2 ( Figure 2 ). The studies of
Hoff et al 26 and Bender et al 20 which were not included in the meta-analysis, found no effect of weight change between pregnancies on GH. The studies of Villamor and Cnattingius, 23 Lynes et al 24 and
Wallace et al 27 showed that, in women who started with normal weight, interpregnancy BMI gain resulted in a higher risk of developing GH during the second pregnancy compared to women who started with overweight or obesity (Table S9 ).
| Preeclampsia
Six studies assessed preeclampsia as an outcome. 23, 24, [27] [28] [29] [30] Three studies were included in the meta-analysis, 23, 24, 27 which found no effect for preeclampsia after loss of >1 kg/m 2 between pregnancies (Table S10 ). The effect of interpregnancy BMI gain was strongest in women with overweight or obesity. 27 
| Cesarean section
Ten studies included cesarean section as an outcome, 16, 20, 24, 26, [31] [32] [33] of which four studies were eligible for meta-analysis. 21, 23, 24, 27 The metaanalysis showed no effect of BMI loss ≥1 kg/m 2 ( Figure S4 : OR Figure 2 ). In the study of Dude et al 31 (not included in the meta-analysis), a decreased risk of a cesarean section after BMI loss of >2 kg/m 2 between pregnancies was shown.
Furthermore, interpregnancy weight gain resulted in an increased risk of a cesarean section. 31 The studies of Knight-Agarwal et al 16 Hoff between the pregnancies had a significantly higher risk of an emergency cesarean section in the second pregnancy compared to women with overweight or obesity before the first pregnancy (Table S11) . 27 
| Preterm birth
Eleven studies analyzed preterm birth as an outcome. 17, 20, 26, 27, [34] [35] [36] [37] [38] [39] [40] Four of these studies were included in the meta-analysis. (Table   S12) . 27, 40 A lower risk for spontaneous preterm birth, though a higher risk for medically indicated preterm birth, was found in women becoming affected by overweight or obesity before the second pregnancy or gaining weight between pregnancies. 36 Interestingly, women with overweight or obesity before the first pregnancy who lost weight were at higher risk for preterm birth between 32 and 36 weeks of gestational age. 39 
| Small for gestational age
In six studies, SGA was assessed. 17, [26] [27] [28] 41, 42 Two of the studies were included in the meta-analysis. 17, 28 In this analysis, it was shown that BMI loss of >1 kg/m 2 was related to a higher risk of SGA ( Figure S6 : (Table S13) . 17, 27, 40 Contrasting results on risks TIMMERMANS ET AL. 6 10 of of SGA were found for women who had overweight or obesity before the first pregnancy and lost weight between pregnancies. 43 (not included in the metaanalysis), the risk of LGA was reduced in women with underweight or normal weight before the first and second pregnancy, while an increased risk was found in most other BMI category shift options.
Hoff et al 26 found no differences between women who were overweight before the first pregnancy and shifted to other BMI categories before the second pregnancy. A decreased risk was found for
LGA after weight loss between pregnancies and an increased risk after weight increase both for women with a BMI < 25 kg/m 2 and women with a BMI ≥25 kg/m 2 before the first pregnancy (Table   S14) . 23, 27, 40, 44 McBain et al did not find significant results in these sensitivity analyses. 17 
| Risk of bias
Cohen's kappa coefficient of all domains of the QUIPS tool was 0.75 (95%CI 0.61-0.89). Seven studies included in the meta-analysis and three studies not included in the meta-analysis were assessed as having a low risk of bias. Eleven studies were assessed as having a moderate risk of bias of which four studies were included in the meta-analysis. Nine studies, all not included in the meta-analysis, had a high risk of bias (Table S15 ). Most studies properly described the process of the databases and statistical models used. The most commonly found risk of bias was related to self-reported prepregnancy weight and height and was thus not based on objective measures. Furthermore, most of the studies with a high risk of bias had insufficiently adjusted for possible confounders. Excluding the studies with a high risk of bias did not affect the results for GDM, preeclampsia, cesarean section, preterm birth, and SGA. For GH and LGA, no studies had to be excluded from the meta-analyses. By excluding the insignificant results of the studies with a high risk of bias, the increased risk for GH and LGA became stronger. The results of this systematic review provide evidence for the impact of weight gain between pregnancies, but might also be relevant for primigravidae. When the adverse effects of interpregnancy weight gain are extrapolated to weight gain in the years before the first TIMMERMANS ET AL. 7 10 of pregnancy, the change from normal weight to overweight and obesity frequently found in this specific life phase is worrisome. Data derived from population surveys in the USA show that obesity prevalence almost doubles, from 21% in female adolescents (12-19 years of age)
to 37% in women of 20 to 39 years of age. This underscores the high risk for gaining weight at reproductive age. 50, 51 This distinct increase in overweight and obesity prevalence from childhood to adolescence is also evident in Europe, Asia, and South America. [52] [53] [54] [55] The prevalence of BMI gain in the studies included in this systematic review indicates that a significant number of women are at risk for interpregnancy BMI gain and thus for an increase in perinatal complications, as 32% to 53% of women had a BMI gain of at least 1 kg/m 2 . 16, [21] [22] [23] [24] 27 Determinants for interpregnancy BMI gain in the studies included in this review were a younger maternal age, longer interpregnancy interval, a lower educational level, and preeclampsia, GH, and a cesarean section during the first pregnancy. 21, 23, 24, 27 Regarding other factors with a potential impact, consensus was not reached on risk factors such as no breastfeeding, smoking, parity, lack of sleeping time, lack of exercise in the postpartum period, and higher prepregnancy BMI. [56] [57] [58] While interpregnancy weight gain is associated with an increased risk for several adverse perinatal outcomes, weight loss between pregnancies only resulted in a reduced risk of limited perinatal complications. Since several studies found evidence for the relationship between overweight/obesity and GH, preeclampsia, cesarean section, and preterm birth, 3, 45, 48 the finding that weight loss only resulted in limited protective effects on these perinatal health risks was unexpected. A possible explanation might be that although BMI reduced in women classified in the "weight loss" group in the studies, the total BMI loss of >1 kg/m 2 without further stratification was too small to have an effect on complications. A larger degree of weight loss, a shift in BMI category from overweight or obesity to normal weight, was not found to decrease the risk of preeclampsia, cesarean section and preterm birth, either. 19, 29, 36 From the studies included in this systematic review, it is unclear which factors contributed to the weight loss that was observed.
This comprehensive systematic review merged data from more than 1 million women globally of which 745,993 women could be included in the meta-analysis. This large sample size allows strong conclusions to be drawn from the results. However, some critical remarks need to be considered. First, only a subset of studies could be included in the meta-analyses. Those studies were all classified as having a low or moderate risk of bias and a large part of the total number of participants could be included in the meta-analyses, which underscores the ability to draw strong conclusions from it. Second, definitions of several outcome measures were heterogeneous. Apart from the differences in inclusion criteria between studies, this may have contributed to the statistical and between-study heterogeneity.
Furthermore, the broad time frame in which included studies collected their data might have contributed to the heterogeneity between studies due to changes in society and public health practices. On the other hand, our limited exclusion criteria enhance the generalizability of our findings. Second, although several confounders were considered in most studies, potential other confounders such as lifestyle behaviors could have influenced the risk on perinatal complications. In addition, the adjustment for confounders was variable across studies.
In summary, the findings of this meta-analysis imply that, in current clinical and research practice on prevention of adverse perinatal outcomes, the focus on specific target groups could be extended. First, our findings indicate that limiting gestational weight gain should not be an exclusive target, but that prevention of weight gain in the interpregnancy period should also be emphasized. In the light of the growing prevalence rates of obesity in women of childbearing age, it is important to start targeting women in the years before conception.
As gestational weight gain is part of the interpregnancy weight change, limiting gestational weight gain should of course not be neglected in prevention strategies. 56 Second, women with normal weight currently tend to escape our attention. 59 Data aggregated in this systematic review stresses the importance of targeting prevention strategies not only on women with overweight and obesity but also on women of normal weight. Third, further research should focus on defining determinants that predict the benefits to be derived from prevention of weight gain, thus allowing targeting specific prevention strategies at those women most at risk. Finally, it was found that prevention strategies should aim at prevention of weight gain in the years before conception and between pregnancies rather than at stimulating weight loss. Due to the lack of studies regarding the effects of these targets, it is recommended to prospectively examine the effects of the prevention of prepregnancy weight gain in women of all BMI categories on perinatal outcomes by a randomized controlled trial, taken into account the potential determinants of weight gain. These studies might be the way forward in the prevention of adverse perinatal outcomes.
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